ECHS1 deficiency and its biochemical and clinical phenotype.
ECHS1
Leigh syndrome
Leigh-like syndrome
metabolic encephalopathy
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
02
06
2022
received:
23
04
2022
accepted:
27
06
2022
pubmed:
21
7
2022
medline:
15
9
2022
entrez:
20
7
2022
Statut:
ppublish
Résumé
ECHS1 gene encodes a mitochondrial enzyme, short-chain enoyl-CoA hydratase (SCEH). SCEH is involved in fatty acid oxidation ([Sharpe and McKenzie (2018); Mitochondrial fatty acid oxidation disorders associated with short-chain enoyl-CoA hydratase (ECHS1) deficiency, 7: 46]) and valine catabolism ([Fong and Schulz (1977); Purification and properties of pig heart crotonase and the presence of short chain and long chain enoyl coenzyme A hydratases in pig and guinea pig tissues, 252: 542-547]; [Wanders et al. (2012); Enzymology of the branched-chain amino acid oxidation disorders: The valine pathway, 35: 5-12]), and the dysfunction of SCEH leads to a severe Leigh or Leigh-like Syndrome phenotype in patients ([Haack et al. (2015); Deficiency of ECHS1 causes mitochondrial encephalopathy with cardiac involvement, 2: 492-509]; [Peters et al. (2014); ECHS1 mutations in Leigh disease: A new inborn error of metabolism affecting valine metabolism, 137: 2903-2908]; [Sakai et al. (2015); ECHS1 mutations cause combined respiratory chain deficiency resulting in Leigh syndrome, 36: 232-239]; [Tetreault et al. (2015); Whole-exome sequencing identifies novel ECHS1 mutations in Leigh, 134: 981-991]). This study aims to further describe the ECHS1 deficiency phenotype using medical history questionnaires and standardized tools assessing quality of life and adaptive skills. Our findings in this largest sample of ECHS1 patients in literature to date (n = 13) illustrate a severely disabling condition causing severe developmental delays (n = 11), regression (n = 10), dystonia/hypotonia and movement disorders (n = 13), commonly with symptom onset in infancy (n = 10), classical MRI findings involving the basal ganglia (n = 11), and variability in biochemical profile. Congruent with the medical history, our patients had significantly low composite and domain scores on Vineland Adaptive Behavior Scales, Third Edition. We believe there is an increasing need for better understanding of ECHS1 deficiency with an aim to support the development of transformative genetic-based therapies, driven by the unmet need for therapies for patients with this genetic disease.
Identifiants
pubmed: 35856138
doi: 10.1002/ajmg.a.62895
doi:
Substances chimiques
Fatty Acids
0
Mitochondrial Trifunctional Protein
EC 2.3.1.16
Enoyl-CoA Hydratase
EC 4.2.1.17
Valine
HG18B9YRS7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2908-2919Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Al Mutairi, F., Shamseldin, H. E., Alfadhel, M., Rodenburg, R. J., & Alkuraya, F. S. (2017). A lethal neonatal phenotype of mitochondrial short-chain enoyl-CoA hydratase-1 deficiency: A lethal phenotype of SCEH deficiency. Clinical Genetics, 91(4), 629-633. https://doi.org/10.1111/cge.12891
Balasubramaniam, S., Riley, L. G., Bratkovic, D., Ketteridge, D., Manton, N., Cowley, M. J., Gayevskiy, V., Roscioli, T., Mohamed, M., Gardeitchik, T., Morava, E., & Christodoulou, J. (2017). Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency. Journal of Inherited Metabolic Disease, 40(5), 745-747. https://doi.org/10.1007/s10545-017-0036-4
Bedoyan, J. K., Yang, S. P., Ferdinandusse, S., Jack, R. M., Miron, A., Grahame, G., DeBrosse, S. D., Hoppel, C. L., Kerr, D. S., & Wanders, R. J. A. (2017). Lethal neonatal case and review of primary short-chain enoyl-CoA hydratase (SCEH) deficiency associated with secondary lymphocyte pyruvate dehydrogenase complex (PDC) deficiency. Molecular Genetics and Metabolism, 120(4), 342-349. https://doi.org/10.1016/j.ymgme.2017.02.002
Carlston, C. M., Ferdinandusse, S., Hobert, J. A., Mao, R., & Longo, N. (2018). Extrapolation of variant phase in mitochondrial short-chain Enoyl-CoA hydratase (ECHS1) deficiency. In E. Morava, M. Baumgartner, M. Patterson, S. Rahman, J. Zschocke, & V. Peters (Eds.), JIMD reports (Vol. 43, pp. 103-109). Springer. https://doi.org/10.1007/8904_2018_111
Downs, J., Jacoby, P., Leonard, H., Epstein, A., Murphy, N., Davis, E., Reddihough, D., Whitehouse, A., & Williams, K. (2019). Psychometric properties of the quality of life inventory-disability (QI-disability) measure. Quality of Life Research: an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 28(3), 783-794. https://doi.org/10.1007/s11136-018-2057-3
Farmer, C., Adedipe, D., Bal, V. H., Chlebowski, C., & Thurm, A. (2020). Concordance of the Vineland Adaptive Behavior Scales, second and third editions. Journal of Intellectual Disability Research, 64(1), 18-26. https://doi.org/10.1111/jir.12691
Ferdinandusse, S., Friederich, M. W., Burlina, A., Ruiter, J. P. N., Coughlin, C. R., Dishop, M. K., Gallagher, R. C., Bedoyan, J. K., Vaz, F. M., Waterham, H. R., Gowan, K., Chatfield, K., Bloom, K., Bennett, M. J., Elpeleg, O., Van Hove, J. L. K., & Wanders, R. J. A. (2015). Clinical and biochemical characterization of four patients with mutations in ECHS1. Orphanet Journal of Rare Diseases, 10, 79. https://doi.org/10.1186/s13023-015-0290-1
Fitzsimons, P. E., Alston, C. L., Bonnen, P. E., Hughes, J., Crushell, E., Geraghty, M. T., Tetreault, M., O'Reilly, P., Twomey, E., Sheikh, Y., Walsh, R., Waterham, H. R., Ferdinandusse, S., Wanders, R. J. A., Taylor, R. W., Pitt, J. J., & Mayne, P. D. (2018). Clinical, biochemical, and genetic features of four patients with short-chain enoyl-CoA hydratase (ECHS1) deficiency. American Journal of Medical Genetics. Part A, 176(5), 1115-1127. https://doi.org/10.1002/ajmg.a.38658
Fong, J. C., & Schulz, H. (1977). Purification and properties of pig heart crotonase and the presence of short chain and long chain enoyl coenzyme A hydratases in pig and guinea pig tissues. The Journal of Biological Chemistry, 252(2), 542-547.
Ganetzky, R. D., Bloom, K., Ahrens-Nicklas, R., Edmondson, A., Deardorff, M. A., Bennett, M. J., & Ficicioglu, C. (2016). ECHS1 deficiency as a cause of severe neonatal lactic acidosis. JIMD Reports, 30, 33-37. https://doi.org/10.1007/8904_2016_538
Haack, T. B., Jackson, C. B., Murayama, K., Kremer, L. S., Schaller, A., Kotzaeridou, U., de Vries, M. C., Schottmann, G., Santra, S., Büchner, B., Wieland, T., Graf, E., Freisinger, P., Eggimann, S., Ohtake, A., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., … Klopstock, T. (2015). Deficiency of ECHS1 causes mitochondrial encephalopathy with cardiac involvement. Annals of Clinical and Translational Neurology, 2(5), 492-509. https://doi.org/10.1002/acn3.189
Huffnagel, I. C., Redeker, E. J. W., Reneman, L., Vaz, F. M., Ferdinandusse, S., & Poll-The, B. T. (2018). Mitochondrial encephalopathy and transient 3-methylglutaconic aciduria in ECHS1 deficiency: Long-term follow-up. JIMD Reports, 39, 83-87. https://doi.org/10.1007/8904_2017_48
Kuwajima, M., Kojima, K., Osaka, H., Hamada, Y., Jimbo, E., Watanabe, M., Aoki, S., Sato-Shirai, I., Ichimoto, K., Fushimi, T., Murayama, K., Ohtake, A., Kohda, M., Kishita, Y., Yatsuka, Y., Uchino, S., Mimaki, M., Miyake, N., Matsumoto, N., … Muramatsu, K. (2021). Valine metabolites analysis in ECHS1 deficiency. Molecular Genetics and Metabolism Reports, 29, 100809. https://doi.org/10.1016/j.ymgmr.2021.100809
Mahajan, A., Constantinou, J., & Sidiropoulos, C. (2017). ECHS1 deficiency-associated paroxysmal exercise-induced dyskinesias: Case presentation and initial benefit of intervention. Journal of Neurology, 264(1), 185-187. https://doi.org/10.1007/s00415-016-8381-z
Marti-Sanchez, L., Baide-Mairena, H., Marcé-Grau, A., Pons, R., Skouma, A., López-Laso, E., Sigatullina, M., Rizzo, C., Semeraro, M., Martinelli, D., Carrozzo, R., Dionisi-Vici, C., González-Gutiérrez-Solana, L., Correa-Vela, M., Ortigoza-Escobar, J. D., Sánchez-Montañez, Á., Vazquez, É., Delgado, I., Aguilera-Albesa, S., … Pérez-Dueñas, B. (2020). Delineating the neurological phenotype in children with defects in the ECHS1 or HIBCH gene. Journal of Inherited Metabolic Disease., 44, 401-414. https://doi.org/10.1002/jimd.12288
Muntean, C., Tripon, F., Bogliș, A., & Bănescu, C. (2022). Pathogenic biallelic mutations in ECHS1 in a case with short-chain enoyl-CoA hydratase (SCEH) deficiency-case report and literature review. International Journal of Environmental Research and Public Health, 19(4), 2088. https://doi.org/10.3390/ijerph19042088
Nair, P., Hamzeh, A. R., Mohamed, M., Malik, E. M., Al-Ali, M. T., & Bastaki, F. (2016). Novel ECHS1 mutation in an Emirati neonate with severe metabolic acidosis. Metabolic Brain Disease, 31(5), 1189-1192. https://doi.org/10.1007/s11011-016-9842-x
Ogawa, E., Shimura, M., Fushimi, T., Tajika, M., Ichimoto, K., Matsunaga, A., Tsuruoka, T., Ishige, M., Fuchigami, T., Yamazaki, T., Mori, M., Kohda, M., Kishita, Y., Okazaki, Y., Takahashi, S., Ohtake, A., & Murayama, K. (2017). Clinical validity of biochemical and molecular analysis in diagnosing Leigh syndrome: A study of 106 Japanese patients. Journal of Inherited Metabolic Disease, 40(5), 685-693. https://doi.org/10.1007/s10545-017-0042-6
Olgiati, S., Skorvanek, M., Quadri, M., Minneboo, M., Graafland, J., Breedveld, G. J., Bonte, R., Ozgur, Z., van den Hout, M. C. G. N., Schoonderwoerd, K., Verheijen, F. W., van IJcken, W. F. J., Chien, H. F., Barbosa, E. R., Chang, H.-C., Lai, S.-C., Yeh, T.-H., Lu, C.-S., Wu-Chou, Y.-H., … Bonifati, V. (2016). Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency. Movement Disorders: Official Journal of the Movement Disorder Society, 31(7), 1041-1048. https://doi.org/10.1002/mds.26610
Peters, H., Buck, N., Wanders, R., Ruiter, J., Waterham, H., Koster, J., Yaplito-Lee, J., Ferdinandusse, S., & Pitt, J. (2014). ECHS1 mutations in Leigh disease: A new inborn error of metabolism affecting valine metabolism. Brain: A Journal of Neurology, 137(Pt 11), 2903-2908. https://doi.org/10.1093/brain/awu216
Raat, H., Landgraf, J. M., Oostenbrink, R., Moll, H. A., & Essink-Bot, M.-L. (2007). Reliability and validity of the infant and toddler quality of life questionnaire (ITQOL) in a general population and respiratory disease sample. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 16(3), 445-460. https://doi.org/10.1007/s11136-006-9134-8
Ruhoy, I. S., & Saneto, R. P. (2014). The genetics of Leigh syndrome and its implications for clinical practice and risk management. The Application of Clinical Genetics, 7, 221-234. https://doi.org/10.2147/TACG.S46176
Sakai, C., Yamaguchi, S., Sasaki, M., Miyamoto, Y., Matsushima, Y., & Goto, Y. (2015). ECHS1 mutations cause combined respiratory chain deficiency resulting in Leigh syndrome. Human Mutation, 36(2), 232-239. https://doi.org/10.1002/humu.22730
Sharpe, A. J., & McKenzie, M. (2018). Mitochondrial fatty acid oxidation disorders associated with short-chain enoyl-CoA hydratase (ECHS1) deficiency. Cell, 7(6), 46. https://doi.org/10.3390/cells7060046
Shayota, B. J., Soler-Alfonso, C., Bekheirnia, M. R., Mizerik, E., Boyer, S. W., Xiao, R., Yang, Y., Elsea, S. H., & Scaglia, F. (2019). Case report and novel treatment of an autosomal recessive Leigh syndrome caused by short-chain enoyl-CoA hydratase deficiency. American Journal of Medical Genetics Part A, 179(5), 803-807. https://doi.org/10.1002/ajmg.a.61074
Tetreault, M., Fahiminiya, S., Antonicka, H., Mitchell, G. A., Geraghty, M. T., Lines, M., Boycott, K. M., Shoubridge, E. A., Mitchell, J. J., Care4Rare Canada Consortium, Michaud, J. L., & Majewski, J. (2015). Whole-exome sequencing identifies novel ECHS1 mutations in Leigh syndrome. Human Genetics, 134(9), 981-991. https://doi.org/10.1007/s00439-015-1577-y
Uesugi, M., Mori, J., Fukuhara, S., Fujii, N., Omae, T., Sasai, H., Ichimoto, K., Murayama, K., Osamura, T., & Hosoi, H. (2020). Short-chain enoyl-CoA hydratase deficiency causes prominent ketoacidosis with normal plasma lactate levels: A case report. Molecular Genetics and Metabolism Reports, 25, 100672. https://doi.org/10.1016/j.ymgmr.2020.100672
Varni, J. W., Seid, M., & Rode, C. A. (1999). The PedsQL: Measurement model for the pediatric quality of life inventory. Medical Care, 37(2), 126-139. https://doi.org/10.1097/00005650-199902000-00003
Wanders, R. J. A., Duran, M., & Loupatty, F. J. (2012). Enzymology of the branched-chain amino acid oxidation disorders: The valine pathway. Journal of Inherited Metabolic Disease, 35(1), 5-12. https://doi.org/10.1007/s10545-010-9236-x
Yamada, K., Aiba, K., Kitaura, Y., Kondo, Y., Nomura, N., Nakamura, Y., Fukushi, D., Murayama, K., Shimomura, Y., Pitt, J., Yamaguchi, S., Yokochi, K., & Wakamatsu, N. (2015). Clinical, biochemical and metabolic characterisation of a mild form of human short-chain enoyl-CoA hydratase deficiency: Significance of increased N-acetyl-S-(2-carboxypropyl)cysteine excretion. Journal of Medical Genetics, 52(10), 691-698. https://doi.org/10.1136/jmedgenet-2015-103231
Yang, H., & Yu, D. (2020). Clinical, biochemical and metabolic characterization of patients with short-chain enoyl-CoA hydratase(ECHS1) deficiency: Two case reports and the review of the literature. BMC Pediatrics, 20(1), 50. https://doi.org/10.1186/s12887-020-1947-z